Zeba Mueed
Overview
Explore the profile of Zeba Mueed including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
60
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rai P, Mueed Z, Chowdhury A, Deval R, Kumar D, Kamal M, et al.
Curr Pharm Biotechnol
. 2021 May;
23(3):361-387.
PMID: 33966618
The coronavirus pandemic hit the world lately and caused acute respiratory syndrome in humans. The causative agent of the disease was soon identified by scientists as SARS-CoV-2 and later called...
2.
Mueed Z, Rai P, Kamal M, Poddar N
CNS Neurol Disord Drug Targets
. 2020 Sep;
20(8):723-735.
PMID: 32885762
Alzheimer's Disease (AD), characterized by abnormally phosphorylated tau, Paired Helical Filaments (PHFs), Neurofibrillary Tangles (NFTs), deregulated mammalian Target Of Rapamycin (mTOR), and Aβ deposits, is a multifactorial disease with sleep...
3.
Mueed Z, Mehta D, Rai P, Kamal M, Poddar N
Curr Pharm Des
. 2020 May;
26(37):4699-4711.
PMID: 32418522
Alzheimer's disease, categorized by the piling of amyloid-β (Aβ), hyperphosphorylated tau, PHFs, NFTs and mTOR hyperactivity, is a neurodegenerative disorder, affecting people across the globe. Osmolytes are known for osmoprotectants...
4.
Mueed Z, Tandon P, Maurya S, Deval R, Kamal M, Poddar N
Front Neurosci
. 2019 Jan;
12:1017.
PMID: 30686983
The hyperphosphorylation of tau protein and the overexpression of mTOR are considered to be the driving force behind Aβ plaques and Neurofibrillay Tangles (NFT's), hallmarks of Alzheimer's disease (AD). It...